Apremilast

Spezifikationen

608141-41-9CAS-Nummer

807-237-6EG-Nummer

N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamideIUPAC-Name

C22H24N2O7SChemische Formel

460.5 g/molMolekulargewicht

Apremilast; 608141-41-9; OTEZLA; CC-10004; CC 10004; CC10004; apremilastum; CHEBI:78540; UP7QBP99PN; N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide; DTXSID30976289; N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide; Acetamide, N-(2-((1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)-; Acetamide, N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-; N-(2-((1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)acetamide; N-(2-((1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)acetamide; RefChem:56446; L04AA32; DTXCID101478388; (+)-N-(2-((1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)acetamide; (S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione; Apremilast (CC-10004); MFCD18782607; (S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide; C22H24N2O7S; CHEMBL514800; N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide; (+)-N-(2-((1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxo- 2,3-dihydro-1H-isoindol-4-yl)acetamide; Apremilast [USAN]; Apremilast [USAN:INN]; UNII-UP7QBP99PN; Apremilast?; HSDB 8221; (S)-Apremilast; Otezla (TN); Apremilast (Standard); APREMILAST [MI]; APREMILAST [INN]; APREMILAST [JAN]; Apremilast (JAN/USAN); APREMILAST [VANDF]; APREMILAST [WHO-DD]; Apremilast Reference Standard; SCHEMBL302992; Apremilast - Bio-X trade mark; GTPL7372; orb1304839; orb3025910; APREMILAST [ORANGE BOOK]; SCHEMBL29350625; SCHEMBL29446192; EX-A336; IMOZEMNVLZVGJZ-QGZVFWFLSA-N; GLXC-90006; cas:608141-41-9;Apremilast; ARD15152; BDBM50248919; EBC-27155; HY-12085R; s8034; AKOS016339660; CCG-269336; CS-0671; DB05676; FA29510; FK-0727; AC-27650; BA164215; DA-61173; HY-12085; SY046906; A6269; SW219856-1; D08860; EN300-7423712; F862501; Q2858961; BRD-K93208532-001-02-5; Z1837762189; (S)-4-Acetylamino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]isoindoline-1,3-dione; (S)-N-{2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}-acetamide; A9L; Acetamide, N-(2-((1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)- 2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)-; N-[2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindolin-4-yl]acetamide; N-[2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide; N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methanesulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide; オテズラSynonyme